Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy.

scientific article published in May 2015

Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YJMCC.2015.04.019
P698PubMed publication ID25939780

P2093author name stringJun Wu
Ren-Ke Li
Richard D Weisel
Shu-Hong Li
Kota Hatta
Zhengbo Shao
Huifang Song
Nathan C Ni
Mansoreh Nazari
Ana Ludke
P2860cites workPutative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycleQ57250342
Downregulation of beta2-microglobulin in human cord blood somatic stem cells after transplantation into livers of SCID-mice: an escape mechanism of stem cells?Q74326208
CNS immune privilege: hiding in plain sightQ24642697
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsQ27001159
The testis in immune privilegeQ28263610
Pluripotency of mesenchymal stem cells derived from adult marrowQ29617959
Adult cardiac stem cells are multipotent and support myocardial regenerationQ29620122
Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients.Q31133190
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac functionQ33863225
Stem cell factor: biology and relevance to clinical practiceQ34313859
Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction.Q34479264
Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step .Q34550669
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammationQ35186813
Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetesQ35568544
Current status of cellular therapy for ischemic heart diseaseQ36141024
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarctionQ36349782
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarctionQ36630155
Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterusQ36802749
Immune privilege and the skinQ37156222
Aging and disease as modifiers of efficacy of cell therapyQ37183949
Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantationQ37501370
Sex hormones and coronary disease: a review of the clinical studiesQ37989456
Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair.Q37995409
Regulatory immune cells in transplantationQ38013048
The immune privilege of testis and gravid uterus: same difference?Q38146307
Myometrial cells induce angiogenesis and salvage damaged myocardium.Q38483643
Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease managementQ41513063
Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repairQ42794686
Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarctionQ43733452
Cardiac side population cells and Sca-1-positive cellsQ44231631
Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytesQ44710997
Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapyQ46748172
An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potentialQ47585419
Further characterization of CD34-low/negative mouse hematopoietic stem cells.Q51089632
Uterine cells are recruited to the infarcted heart and improve cardiac outcomes in female rats.Q51351109
P304page(s)116-128
P577publication date2015-05-01
P1433published inJournal of Molecular and Cellular CardiologyQ2061932
P1476titleUterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy.
P478volume84

Reverse relations

cites work (P2860)
Q53486196Uterine cells-an immunoprivileged cell source for therapy-but are they for everyone?
Q52899317Uterine-Derived CD11b Cells Significantly Increase Vasculogenesis and Promote Myocardial Healing in Ischemic Cardiomyopathy.

Search more.